About Frank Troxell

This author has not yet filled in any details.
So far Frank Troxell has created 5 blog entries.

NuMedii Names Industry Veteran Heather Arnett, Ph.D. as Vice President of Research

By | 2018-11-01T08:54:53+00:00 November 1st, 2018|

SAN MATEO, Calif., November 1, 2018 – NuMedii, Inc., today announced the appointment of Heather Arnett, Ph.D., as Vice President, Research. Heather is leading research discovery and early development at NuMedii based on the company’s Artificial Intelligence Drug Discovery (AIDD) technology, which enables the discovery of novel targets and precision drug candidates across a number [...]

NuMedii Announces Research Collaboration With Leading Academic Research Institution to Explore New Targets and Therapeutics for Pancreatitis

By | 2018-11-01T09:00:49+00:00 November 1st, 2018|

SAN MATEO, Calif., November 1, 2018 – NuMedii, Inc., today announced the formation of a research collaboration with Johns Hopkins School of Medicine with the goal of discovering new targets and therapeutic options for pancreatitis. The collaboration brings together deep clinical expertise with NuMedii’s Artificial Intelligence Drug Discovery (AIDD) technology, which will enable the discovery [...]

NuMedii Announces Strategic Research Collaboration with Two Leading Academic Research Institutions Utilizing Single-Cell Sequencing to Identify Precision Therapeutics for IPF

By | 2018-07-10T07:53:58+00:00 July 10th, 2018|

SAN MATEO, Calif., July 10, 2018 – NuMedii, Inc., today announced the formation of a strategic research collaboration with Yale School of Medicine and Brigham and Women’s Hospital with the goal of utilizing single-cell sequencing to identify novel precision therapies and biomarkers in idiopathic pulmonary fibrosis (IPF). An orphan disease, IPF is a chronic, progressive [...]

NuMedii Expands Board of Directors and Scientific Advisory Board with the Addition of Two Oncology Experts

By | 2018-07-09T09:07:47+00:00 June 20th, 2018|

MENLO PARK, Calif., June 20, 2018 – NuMedii, Inc., today announced an expansion of its Board of Directors with the appointment of Athena M. Countouriotis, MD. In addition, Zemin Zhang, PhD, has joined the company’s Scientific Advisory Board. Drs. Countouriotis and Zhang are two industry leaders with expertise in cancer clinical development, and genomics and [...]

World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board

By | 2018-07-09T09:11:38+00:00 January 8th, 2018|

MENLO PARK, Calif., January 8, 2018 – NuMedii, Inc. today announced the formation of an Idiopathic Pulmonary Fibrosis (IPF) Advisory Board consisting of the world’s leading experts in interstitial lung disease: Naftali Kaminski, MD; David A. Schwartz, MD; Kevin Brown, MD; Toby Maher, MD, PhD; Gisli Jenkins, MD, PhD; Zea Borok, MD; and, Paul Wolters, [...]